376 related articles for article (PubMed ID: 14672249)
21. [Risk factors of schizophrenia development in patients with amphetamines dependence and psychosis (amphetamine-induced psychosis and schizophrenia), and without psychosis].
Rabe-Jabłońska J; Mirek M; Pawełczyk T
Psychiatr Pol; 2012; 46(4):571-84. PubMed ID: 23214160
[TBL] [Abstract][Full Text] [Related]
22. Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.
McKetin R; Gardner J; Baker AL; Dawe S; Ali R; Voce A; Leach LS; Lubman DI
Psychiatry Res; 2016 Apr; 238():166-171. PubMed ID: 27086229
[TBL] [Abstract][Full Text] [Related]
23. Premorbid personality and positive and negative symptoms in schizophrenia.
Peralta V; Cuesta MJ; de Leon J
Acta Psychiatr Scand; 1991 Oct; 84(4):336-9. PubMed ID: 1746284
[TBL] [Abstract][Full Text] [Related]
24. Relapse antecedents for methamphetamine use and related factors in Taiwanese adolescents.
Yen CF; Chang YP
Psychiatry Clin Neurosci; 2005 Feb; 59(1):77-82. PubMed ID: 15679544
[TBL] [Abstract][Full Text] [Related]
25. An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.
Jacobs E; Fujii D; Schiffman J; Bello I
Cogn Behav Neurol; 2008 Jun; 21(2):98-103. PubMed ID: 18541986
[TBL] [Abstract][Full Text] [Related]
26. Does the pattern of amphetamine use prior to incarceration predict later psychosis?--a longitudinal study of amphetamine users in the Swedish criminal justice system.
Rognli EB; Håkansson A; Berge J; Bramness JG
Drug Alcohol Depend; 2014 Oct; 143():219-24. PubMed ID: 25146382
[TBL] [Abstract][Full Text] [Related]
27. Is there a discrete negative symptom syndrome in people who use methamphetamine?
Voce A; Burns R; Castle D; Calabria B; McKetin R
Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
[TBL] [Abstract][Full Text] [Related]
28. Substance initiation sequences among Taiwanese adolescents using methamphetamine.
Yen CF; Yang YH; Ko CH; Yen JY
Psychiatry Clin Neurosci; 2005 Dec; 59(6):683-9. PubMed ID: 16401244
[TBL] [Abstract][Full Text] [Related]
29. Suicidal ideation and correlates in Taiwanese adolescent methamphetamine users.
Yen CF; Shieh BL
J Nerv Ment Dis; 2005 Jul; 193(7):444-9. PubMed ID: 15985838
[TBL] [Abstract][Full Text] [Related]
30. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
[No Abstract] [Full Text] [Related]
31. Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.
Srisurapanont M; Arunpongpaisal S; Wada K; Marsden J; Ali R; Kongsakon R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):959-64. PubMed ID: 21277930
[TBL] [Abstract][Full Text] [Related]
32. The profile of psychiatric symptoms exacerbated by methamphetamine use.
McKetin R; Dawe S; Burns RA; Hides L; Kavanagh DJ; Teesson M; McD Young R; Voce A; Saunders JB
Drug Alcohol Depend; 2016 Apr; 161():104-9. PubMed ID: 26874915
[TBL] [Abstract][Full Text] [Related]
33. Positive and negative symptoms/syndromes in schizophrenia: reliability and validity of different diagnostic systems.
Peralta V; Cuesta MJ; de Leon J
Psychol Med; 1995 Jan; 25(1):43-50. PubMed ID: 7792361
[TBL] [Abstract][Full Text] [Related]
34. Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.
Plüddemann A; Dada S; Parry CD; Kader R; Parker JS; Temmingh H; van Heerden S; de Clercq C; Lewis I
Afr J Psychiatry (Johannesbg); 2013 Jan; 16(1):45-9. PubMed ID: 23417636
[TBL] [Abstract][Full Text] [Related]
35. Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment.
Lecomte T; Mueser KT; MacEwan W; Thornton AE; Buchanan T; Bouchard V; Goldner E; Brink J; Lang D; Kang S; Barr AM; Honer WG
J Nerv Ment Dis; 2013 Dec; 201(12):1085-9. PubMed ID: 24284645
[TBL] [Abstract][Full Text] [Related]
36. Subjective quality of life in recent onset of psychosis patients and its association with sociodemographic variables, psychotic symptoms and clinical personality traits.
Sevilla-Llewellyn-Jones J; Cano-Domínguez P; de-Luis-Matilla A; Espina-Eizaguirre A; Moreno-Kustner B; Ochoa S
Early Interv Psychiatry; 2019 Jun; 13(3):525-531. PubMed ID: 29278295
[TBL] [Abstract][Full Text] [Related]
37. Methamphetamine psychosis: epidemiology and management.
Glasner-Edwards S; Mooney LJ
CNS Drugs; 2014 Dec; 28(12):1115-26. PubMed ID: 25373627
[TBL] [Abstract][Full Text] [Related]
38. A developmentally-stable pattern of premorbid schizoid-schizotypal features predicts psychotic transition from the clinical high-risk for psychosis state.
Kotlicka-Antczak M; Karbownik MS; Pawełczyk A; Żurner N; Pawełczyk T; Strzelecki D; Urban-Kowalczyk M
Compr Psychiatry; 2019 Apr; 90():95-101. PubMed ID: 30831438
[TBL] [Abstract][Full Text] [Related]
39. Primary and substance-induced psychotic disorders in methamphetamine users.
Hides L; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB
Psychiatry Res; 2015 Mar; 226(1):91-6. PubMed ID: 25677394
[TBL] [Abstract][Full Text] [Related]
40. [Amphetamine-induced psychosis or schizophrenia?].
Rognli EB; Medhus SE; Bramness JG
Tidsskr Nor Laegeforen; 2015 Feb; 135(3):249-51. PubMed ID: 25668544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
